Kandilli, B. Et Al. 2021. Orally disintegrating tablet containing carbamazepine and levetiracetam: formulation and in vitro and in vivo characterization. Drug Development and Industrial Pharmacy , vol.47, no.7 , 1153-1165.

Kandilli, B., UĞUR KAPLAN, A. B., ÇETİN, M., TAŞPINAR, N., Genc, S., Yeni, Y., ... ERTUĞRUL, M. S.(2021). Orally disintegrating tablet containing carbamazepine and levetiracetam: formulation and in vitro and in vivo characterization. Drug Development and Industrial Pharmacy , vol.47, no.7, 1153-1165.

Kandilli, Busra Et Al. "Orally disintegrating tablet containing carbamazepine and levetiracetam: formulation and in vitro and in vivo characterization," Drug Development and Industrial Pharmacy , vol.47, no.7, 1153-1165, 2021

Kandilli, Busra Et Al. "Orally disintegrating tablet containing carbamazepine and levetiracetam: formulation and in vitro and in vivo characterization." Drug Development and Industrial Pharmacy , vol.47, no.7, pp.1153-1165, 2021

Kandilli, B. Et Al. (2021) . "Orally disintegrating tablet containing carbamazepine and levetiracetam: formulation and in vitro and in vivo characterization." Drug Development and Industrial Pharmacy , vol.47, no.7, pp.1153-1165.

@article{article, author={Busra Kandilli Et Al. }, title={Orally disintegrating tablet containing carbamazepine and levetiracetam: formulation and in vitro and in vivo characterization}, journal={Drug Development and Industrial Pharmacy}, year=2021, pages={1153-1165} }